Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 3
1986 3
1987 6
1988 4
1989 6
1990 5
1991 2
1992 5
1993 2
1994 6
1995 1
1996 3
1997 2
1998 2
1999 2
2000 1
2001 3
2003 2
2004 4
2005 4
2006 2
2007 2
2008 4
2009 6
2010 6
2011 9
2012 5
2013 8
2014 2
2015 5
2016 2
2017 1
2018 2
2019 3
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE; AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Dorman SE, et al. N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400. N Engl J Med. 2021. PMID: 33951360 Free PMC article. Clinical Trial.
Genomics and the chemotherapy of leprosy.
Grosset JH, Cole ST. Grosset JH, et al. Lepr Rev. 2001 Dec;72(4):429-40. doi: 10.5935/0305-7518.20010051. Lepr Rev. 2001. PMID: 11826479 Review.
Fluoroquinolones, tuberculosis, and resistance.
Ginsburg AS, Grosset JH, Bishai WR. Ginsburg AS, et al. Among authors: grosset jh. Lancet Infect Dis. 2003 Jul;3(7):432-42. doi: 10.1016/s1473-3099(03)00671-6. Lancet Infect Dis. 2003. PMID: 12837348 Review.
Treatment of tuberculosis in HIV infection.
Grosset JH. Grosset JH. Tuber Lung Dis. 1992 Dec;73(6):378-83. doi: 10.1016/0962-8479(92)90044-K. Tuber Lung Dis. 1992. PMID: 1337993 Review.
Latent tuberculosis infection.
Nuermberger E, Bishai WR, Grosset JH. Nuermberger E, et al. Among authors: grosset jh. Semin Respir Crit Care Med. 2004 Jun;25(3):317-36. doi: 10.1055/s-2004-829504. Semin Respir Crit Care Med. 2004. PMID: 16088473
Present status of chemotherapy for tuberculosis.
Grosset JH. Grosset JH. Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. doi: 10.1093/clinids/11.supplement_2.s347. Rev Infect Dis. 1989. PMID: 2652251 Review.
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
Kling A, Lukat P, Almeida DV, Bauer A, Fontaine E, Sordello S, Zaburannyi N, Herrmann J, Wenzel SC, König C, Ammerman NC, Barrio MB, Borchers K, Bordon-Pallier F, Brönstrup M, Courtemanche G, Gerlitz M, Geslin M, Hammann P, Heinz DW, Hoffmann H, Klieber S, Kohlmann M, Kurz M, Lair C, Matter H, Nuermberger E, Tyagi S, Fraisse L, Grosset JH, Lagrange S, Müller R. Kling A, et al. Among authors: grosset jh. Science. 2015 Jun 5;348(6239):1106-12. doi: 10.1126/science.aaa4690. Science. 2015. PMID: 26045430
119 results